Reduced antihypertensive treatment with maintained ambulatory blood pressure control following weight loss in type 2 diabetes.

Blood PressJun 5, 2026 (epub)
Clinical ResearchEndocrinologyCardiology

Lucas Gladzki, Mattias Brunström, Julia Otten

✦ AI-curated · Sources linked

In 30 seconds

This single-arm intervention trial studied 32 adults with type 2 diabetes and hypertension undergoing a dietary weight-loss program. After 12 months, the median number of antihypertensive medications decreased from 2 to 1 (p = 0.004), while office and ambulatory blood pressure remained stable despite reduced medication use.

Key findings

  • Mean weight loss at 12 months was 11.6 ± 6.0 kg.
  • The median number of antihypertensive medications decreased from 2 to 1 (p = 0.004).
  • Antihypertensive treatment use decreased from 88% to 59%.
  • Night-time systolic blood pressure variability decreased (p < 0.05).

Why it matters

This study highlights the potential for weight loss to reduce the need for antihypertensive medications in patients with type 2 diabetes, while maintaining stable blood pressure control, which may inform treatment strategies in this population.

Source

Published in Blood Press. This summary was written by xxcode from the publication's abstract and metadata. It is not peer reviewed and is not a substitute for the original article. For clinical decisions, review the original publication.

ShareTelegramLinkedIn

AI-generated summaries may contain errors or omissions. Verify clinically important information with the original publication.

More in Endocrinology

Want this personalized?

Stop searching the literature. Choose what you follow and xxcode will build your personalized medical digest.

  • Your specialties
  • Your filters and thresholds
  • Clinical Research + Case Reports, tuned separately
  • Automatic weekly delivery
  • Audio and text

Prefer listening? Personalized audio digests are available with Pro.

Stay updated for free

Get the 3 most interesting publications in one specialty each week.

Weekly email. Unsubscribe anytime.